16:15 EDT MoonLake Immunotherapeutics files $1B mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MLTX:
- Palantir downgraded, Shopify upgraded: Wall Street’s top analyst calls
- Needham starts MoonLake with Buy rating, $76 price target
- MoonLake Immunotherapeutics initiated with a Buy at Needham
- Largest borrow rate increases among liquid names
- MoonLake Immunotherapeutics reports Q2 EPS (23c), consensus (27c)